Director Declaration
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your ONT notes
Pursuant to Listing Rule 6.4.9 R(2), Oxford Nanopore Technologies plc (the "Company") confirms that Heather Preston, Non-Executive Director of the Company, was appointed to the Board of Aligos Therapeutics (Nasdaq: ALGS) as Non-Executive Director effective 7 August 2024.
[ENDS]
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.